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Objective: This paper briefly discusses caries prevalence, the multi-factorial nature of caries
etiology, caries risk and the role and efficacy of fluoride. The paper also highlights research
on bacterial metabolism which provided understanding of the mouth’s natural defenses
against caries and the basis for the development of a new technology for the everyday
prevention and treatment of caries. Finally, evidence that the technology complements and
enhances the anti-caries efficacy of fluoride toothpaste is summarized.
Conclusions: Global data show that dental caries is a prevalent disease, despite the success-
ful introduction of fluoride. Caries experience depends on the balance between consump-
tion of sugars and oral hygiene and the use of fluoride.
Three scientific concepts are fundamental to newmeasures to detect, treat and monitor
caries: (1) dental caries is a dynamic process, (2) dental caries is a continuum of stages from
reversible, pre-clinical to irreversible, clinically detectable lesions, and (3) the caries process
is a balance of pathological and protective factors that can be modulated to manage caries.
Fluoride functions as a protective factor by arresting and reversing the caries process, but
fluoride does not prevent pathological factors that initiate the process. A novel technology,
based upon arginine and an insoluble calcium compound, has been identified which targets
dental plaque to prevent initiation of the caries process by reducing pathological factors. As
the mechanisms of action of arginine and fluoride are highly complementary, a new
dentifrice, which combines argininewith fluoride, has been developed and clinically proven
to provide superior caries prevention.
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and a public health concern
Despite the highly successful introduction of fluoride, dental
caries is a globally prevalent oral health issue and a continuing
public health concern.1–3 Our understanding of global dental
caries patterns has grown over the past several decades. The* Tel.: +1 732 878 6236; fax: +1 732 878 7222.
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Open access under CC BY-NC-ND license.published data demonstrate that caries experience varies
widely among populations, both within individual highly
developed countries, such as the United States, and from
country-to-country in developing and emerging economies.4
Detailed analysis of the changing global patterns of caries
experience over several decades has led investigators to
broadly categorize caries experience in three groups.5,6 The
first comprises populations with low caries experience (mean
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year olds), typically constant over time, found largely in rural
populations in, for example, China, Africa, and remote areas of
South America. The second comprises populations with
moderate to high caries experience (mean DMFT =3–4 and
higher in 12-year olds), typically increasing over time, found
largely in newly industrialized populations in developing and
emerging economies, including Latin America, Central and
Eastern Europe, and Asia. These levels of caries experience
have been attributed, at least in part, to the introduction and
availability of dietary sugars coupled with infrequent or
inadequate oral hygiene. The third comprises populations
with low caries experience (meanDMFT1 in 12-year olds), as
a result of a dramatic decline over time, found largely in
established market economies, such as North America,
Western Europe, Australia, and Japan. This decline in caries
experience, which primarily results from the introduction of
fluoride, has been accompanied by an increase in tooth
retention in older adults. Interestingly, restorative dentistry in
these populations has changed from a heavy focus on primary
cavities in children and adolescents in the 1970s to a focus on
‘‘recurrent’’ caries in adults in 2000, reflecting the pattern of
caries experience across life stages.6
Whilst the data from the developing and emerging
countries clearly show that dental caries is a significant oral
health andpublic health issue, at face value, thedata from the
industrialized countries suggest that caries is effectively
managed and is no longer a major health problem. However,
this is not the reality. The NHANES III study showed that
dental caries remains an oral health problem in the USA.7
Both the caries prevalence and severity data increased with
age, showing that dental caries is not only a childhood
disease, but also a prevalent adult problem. The data also
showed that 80% of caries experiencewas found in 25% of the
population, a ‘‘high risk’’ subset comprising groups of low
social economic status.8 The data from Europe and Australia
show similar patterns, with dramatic declines in overall
caries experience, yet widespread disparities in ‘‘high risk’’
groups, attributed to poor oral hygiene, diets rich in refined
sugars and a number of factors stemming from low economic
status.4
Interestingly, in 2012, a critical review contrasting caries
trends in children in Vietnamese and Australian populations
confirmed the wide variability in caries experience driven by
socio-economic inequality.9 Likewise, a systematic review of
dental caries in adults, published in the same year, revealed
that social factors, such as education level, income and
occupation are associated with caries.10
Prevalence data also clearly demonstrate that dental caries
is a disease which may affect individuals during each life
stage, from birth through adolescence and adulthood to old
age.11 It appears that increasing caries experiencewith age is a
broad global phenomenon resulting in an increasing need for
caries diagnosis and management, both preventive and
restorative, across life stages. In addition, gingival recession
increasingly occurs in older adults, exposing the tooth root
and posing root caries as a potential additional problem.11
Thus, whilst dental caries has declined on a global basis over
thepast several decades, dental caries is an ongoing global oral
health and public health problem throughout life.12Both the prevalence and severity of dental caries has been
driven by two key behavioural factors: increasing caries has
been driven by increasing consumption of refined sugars,
whilst decreasing caries has been driven by improved oral
hygiene and the effective use of fluoride. In essence, caries
incidence and severity reflect the relative importance of these
two factors to the individual and in the population.4
The fact that dental caries is prevalent globally does not, by
itself, merit it as amajor issue. However, the significant cost to
treat the disease, as well as its impact on individuals and
populationswho cannot afford or do not have access to dental
care, elevate dental caries to an oral health and public health
issue. The most tangible costs are, of course, for dental
restorations. A less tangible cost is the pain and suffering
associated with caries; it can diminish the quality of life and
may lead to malnutrition and other health problems, whilst
the cosmetic consequences of dental caries can impact self-
esteem and self-confidence.2. Current concepts of the etiology of dental
caries and the caries continuum
Dental caries is a multi-factorial disease with a complex
etiology. The root cause of dental caries is bacterial production
of acids, from dietary sugars and carbohydrates, at the
interface of residual dental plaque and a susceptible tooth
surface.1,13 Time is a critical factor in determining caries
severity, and factors, such as saliva function, behaviour,
education and socioeconomic status, are also important.14,15
Dental plaque is a complex, highly diverse oral biofilm
which develops on tooth surfaces over time and may remain
in hard-to-brush areas, after brushing, for extended peri-
ods.1,13 The properties of dental plaque are typical of biofilms.
It is a highly structured, spatially organized and metabolically
integrated community of bacteria which interact and com-
municate by gene transfer and by secretion of signaling
molecules. Specific species within the community are code-
pendent and the community as a whole enjoys increased
metabolic efficiency, greater resistance to stress, and en-
hanced virulence compared to its planktonic counterparts.16,17
The composition and metabolism of plaque biofilm varies
from site-to-site, for example on the teeth versus on the
tongue, and deep in pits and fissures versus at gingivalmargin,
yet at a particular site can remain relatively stable over time, in
microbial homeostasis. Significant changes in the environ-
ment, however, can trigger changes from a ‘‘healthy’’ plaque
biofilm to a ‘‘pathogenic’’ plaque biofilm, thereby predisposing
a site to disease.18
The production of acid from fermentable dietary sugar can
cause a significant change in biofilmenvironment that triggers
a change from a ‘‘healthy’’ to a ‘‘cariogenic’’ plaque, predis-
posing the site to dental caries. Adaptive mechanisms play a
critical role in the presence and persistence of specific
bacterial species in the plaque biofilm. The aciduric/acido-
genic bacteria implicated in the pathogenesis of dental caries,
i.e., themutans streptococci, would be unable to survive under
the acid conditions they create at the biofilm–tooth interface,
if they did not possess amechanismof acid tolerance. Many of
the bacterial species associatedwith oral health have difficulty
[(Fig._2)TD$FIG]
Fig. 2 – Schematic illustration of the caries balance in (a)
health and (b) disease (adapted from Featherstone20).
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this acid tolerance mechanism.1,13 However, several of these
bacterial species possess an alternativemechanism, known as
the arginine deiminase pathway, which breaks down the
arginine present in saliva, produces ammonia and neutralizes
plaque acids, and enables them to survive.1,13 Thus, this
mechanism protects the biofilm and prevents a change from a
‘‘healthy’’ to a ‘‘cariogenic’’ plaque.
When acid is formed at the tooth–biofilm interface in
sufficient amounts and for sufficient time periods, the local pH
drops below the critical pH (the pH below which calcium and
phosphate from the tooth mineral are solubilized), the local
environment at the interface becomes under-saturated in
calcium and phosphate, and this drives dissolution of calcium
and phosphate from the tooth enamel into the surrounding
local environment, resulting in de-mineralization and loss of
tooth mineral.1,13,19 When fluoride is present, the critical pH
for solubilization of calcium and phosphate ions is lowered,
with the result that a lower plaque pH can be tolerated before
solubilization occurs (Fig. 1).19
One of the most important concepts is that dental caries is
a dynamic and reversible process.20,21When the caries process
affects the crown of the tooth, it initially leads to a ‘‘sub-
surface’’ de-mineralized zone below the surface of the intact
enamel, known as an ‘‘early caries’’ lesion.22 Early lesions can
be arrested and reversed by re-mineralization. Re-mineraliza-
tion occurs following de-mineralization, when the acid
challenge is removed, saliva becomes saturated in calcium
and phosphate, once again, and these calcium and phosphate
ions are driven back into the de-mineralized tooth tissue
resulting in net mineral gain and ‘‘repair’’ of the enamel’s
hydroxyapatite structure.19,20 However, if an early lesion is left
untreated and continues to de-mineralize, it progresses
beyond the point where it can be effectively reversed and
re-mineralized, reaching the clinical end point of cavitation,
which needs professional intervention, i.e., restoration.
A second important concept is that the caries process is a
balance between pathological factors and protective factors.
Fig. 2a and b illustrate the caries balance for caries free and
caries prone individuals, respectively. If the pathological
factors outweigh the protective factors, then the caries
process leads to conditions of net de-mineralization, and
[(Fig._1)TD$FIG]
Fig. 1 – Stephan curve showing the effects of a sugar
challenge on plaque pH. Fluoride lowers the ‘‘Critical pH’’
belowwhich solubilization of calcium and phosphate from
the tooth occurs. Typical time to return to resting pH is
45–60 min (adapted from Kleinberg19).the formation or progression of a caries lesion. If, on the other
hand, the protective factors dominate, then the caries process
results in net re-mineralization and existing caries lesions are
arrested and reversed.21 Dental professionals have found this
concept helpful in assessing the pathological and protective
factors in their patients and in recommending specific
preventive and treatment steps to reduce pathological factors
and to increase protective factors, to help manage the caries
process.21
A third important concept is that dental caries is a
continuum of disease states, ranging from sub-clinical early
lesions to advanced, clinically detectable lesions. Clinical
researchers have classified the various stages of primary
coronal caries lesions and have defined diagnostic criteria for
the detection andmonitoring of intact and cavitated lesions in
caries clinical trials and in clinical practice.23 Early caries
lesions, however, require more advanced and discerning
methods of detection and monitoring, and this has important
consequences for caries management and for the develop-
ment and validation of new technologies to arrest and reverse
early caries lesions.24
The preceding discussion has implicitly focused upon
coronal (enamel) caries, but is also relevant to root (dentin)
caries. Dental plaque biofilm, host tissue, and sugar are also
critical factors in the development of root caries. An additional
factor is the presence of gingival recession and exposure of the
tooth root.25 The critical pH for dentin de-mineralization is
higher than the critical pH for enamel, which has suggested
that more efficacious measures may be required to reduce de-
mineralization and enhance re-mineralization of dentin.26 In
practice, root caries lesions can also be arrested and reversed
and are, thus, amenable to preventive measures.
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reducing risk factors to prevent and treat dental
caries
Understanding of the factors driving the changing patterns of
caries experience at the population level has sparked interest
in the assessment and management of caries risk.27 There is
general acceptance that the true risk factors in dental caries
are the presence of susceptible tooth surfaces, acid-producing
bacteria, including Streptococcus mutans, frequent sugar intake;
impaired salivary function, poor oral hygiene, past caries
experience; inadequate fluoride exposure, limited access to
dental care; and low socioeconomic status.12,21,28–30 Under-
standing risk factors enables caries risk management and
targeted prevention at both the population and the individual
level. At its simplest, caries risk can be reduced by reducing
caries risk factors.
The risk factors that can be readily addressedwith new and
improved oral care products are the two key biological factors:
(1) the susceptible host tissue and (2) the cariogenic bacteria in
the plaque biofilm, and as a consequence of the latter, the
resulting production of bacterial acid.4
Historically, much of caries research and its translation
into practical prevention and treatment measures have been
focused on the host tissue. Specifically, attempts to reduce
caries risk have focused on reducing the tooth’s susceptibility
to acid attack by rendering the tooth’s surface less vulnerable
to de-mineralization. In addition, by enhancing the uptake of
calcium and phosphate ions into de-mineralized tissue, re-
mineralization can be increased. Suchmeasures to reduce the
risk of caries can increase protective factors to restore the
caries balance.4
In contrast, there has been limited research on the plaque
biofilm, and its harmful consequences, that has translated
into practical prevention and treatment measures. In princi-
ple, routes to reduce risk by targeting the plaque biofilm to
reduce cariogenic challenge include: (1) reduction of total
biofilm biomass, (2) inhibition of bacterial acid production and
(3) promotion of microbial homeostasis and a dynamic
balance favouring organisms associated with ‘‘health’’ within
plaque biofilm. Suchmeasures can reduce the risk of caries by
reducing pathological factors to restore the caries balance.44. The role and efficacy of fluoride in reducing
and preventing caries
The primary route to control the harmful effects of the plaque
biofilm in initiating and perpetuating the caries process is
thorough and effective removal of dental plaque fromall tooth
surfaces on a routine basis.31 However, many individuals lack
the knowledge, skills or motivation to achieve the necessary
level of plaque control to be caries free, which is why
therapeutic agents play an important role in supplementing
mechanical oral hygiene.32,33
The dramatic decline in caries in developed countries over
thepast several decadeshas beenattributed to the introduction
of fluoride as a caries preventive agent. The widespread use of
fluoride toothpaste has been widely acknowledged to be thesingle most important factor contributing to this decline in
caries.34,35 Indeed, fluoride is the only anti-caries agent that is
routinely used as part of everyday oral hygiene by all segments
of the population and this is likely because the benefits of
fluoride are clinically proven in a spectrumof populations from
youngchildrentoolderadults.36Several comprehensiveclinical
reviews, which include a Cochrane systematic review, have
shown that regular brushing with fluoride toothpaste reduces
the development of coronal cavities by approximately 25%
compared to brushing with non-fluoride toothpaste.37–42Addi-
tionally, a recent systematic review and meta-analysis of data
from pre-school children has affirmed the effectiveness of
1000–1500 ppm fluoride toothpaste in reducing caries in
primary teeth.
43
The fluoride source itself is not critical to its
effectiveness in cavity prevention. The Cochrane systematic
review, which analysed the clinical evidence from 70 clinical
studies, concluded that there is no evidence for a significant
difference in efficacy of toothpastes formulated with different
forms of fluoride.40 Fluoride toothpastes are also clinically
proven to reduce the development and progression of root
caries.26,44
Fluoride is clinically effective in preventing the caries
process and reducing the formation of cavities because it acts
directly on the tooth mineral to prevent mineral loss. During
use of a fluoride toothpaste or mouth rinse, low levels of
fluoride are delivered to the oral cavity, where they are
retained in reservoirs on the tooth surface and the soft tissues
for sufficient time periods (>12 h) to exert sustained biological
activity.45–47 Specifically, these low, sustained levels of
fluoride reduce the critical pH value below which calcium
and phosphate ions are solubilized from tooth enamel and
dentin, thus, reducing de-mineralization.48–50 They also
enhance re-mineralization;48,51 formation of calcium fluoride
on the tooth surface acts as a reservoir of fluoride and
significant drops in pH trigger fluoride release which drives
calcium and phosphate ions back into the de-mineralized
hydroxyapatite structure within the caries lesion.52
In summary, fluoride dentifrices, and other topical fluoride
products, reducedental cariesby targeting the toothsurfaceand
reducing its susceptibility to acid attack. Fluoride arrests the
caries process, reducing de-mineralization and increasing re-
mineralizationofde-mineralizedtissues.However, convention-
al fluoride toothpastes andmouth rinses have their limitations
forhighrisk individuals,especially thosewithhighplaquelevels
and frequentsugar intake. Fluoridedoesnotactupontheplaque
biofilm, an important modifiable factor in dental caries, to
reduce cariogenic challenge. Specifically, fluoride does not
primarily: (1) reduce total biofilm biomass, (2) inhibit bacterial
acidproductionor (3)promotemicrobialhomeostasiswithinthe
plaque biofilm and a dynamic balance favouring organisms
associatedwith ‘‘health’’. Thus, topical fluorideproductshelp to
control, but cannot completely prevent dental caries.14.5. Oral bacterial metabolism, the mouth’s
natural defenses against caries, and the basis of a
new technology for caries management
More than a century ago, the emerging field of microbiology
provided important new insights into the cause of many
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to understanding dental disease and the role of bacteria in the
oral cavity. The results of his pioneering studies led Miller to
formulate his acid decalcification theory and to describe a
discrete two-step process for the disease, now known as
dental caries. He described how, in the first step, oral bacteria
metabolize fermentable carbohydrates, primarily sugars but
also starches, to produce acid, which in a second step is able to
de-mineralize the tooth mineral to initiate and sustain the
caries process.53 Whilst Miller’s work has been superseded by
many decades of research into virtually every aspect of dental
caries, this early understanding remains a cornerstone of new
approaches to prevent and treat dental caries.
The complexity of the oral flora and the role of specific
species in the development and progression of caries have
provoked interesting debate for many years. Two schools of
opposing thought developed as investigators addressed the
questions: ‘‘Is caries caused by a specific pathogenic species or
dental plaque as a whole?’’, and ‘‘Is caries a classical infectious
disease or does it result from an ecological overgrowth?’’54,55
Proponents of the specific plaque hypothesis and caries as a
classic infection have supported this theory with observations
of frequent association of the mutans streptococci, especially
S. mutans, and lactobacilli species with caries.54 On the other
hand, proponents of the non-specific hypothesis have advo-
cated that dental caries can occur in the absence of mutans
streptococci and lactobacilli species and in the presence of
other bacteria that can produce acid.55 It appears that aspects
of each of these two opposing hypotheses havemerit in respect
of the true role of the oral flora in caries causation. Research
has shown that a spectrum of resident bacterial species exists
that are both acid-producing and acid tolerant, and are
sufficiently numerous in the oral cavity to contribute to the
development and progression of caries.56 Further, research has
shown that caries can be triggered by an increase in acid-
producing species in the plaque biofilm and/or a decrease in
resident species that produce counteracting alkali.55
Several decades of research in the detailed mechanisms of
oral bacterial metabolism and the mouth’s natural defenses
against dental caries has provided a sound scientific basis for
the development of a new technology for caries management
based upon arginine, an insoluble calcium compound, and
fluoride. Specifically, Kleinberg and coworkers conducted
studies of the metabolic pathways involved in carbohydrate
metabolism, and the factors driving acid formation, which
provided a rational basis for the cause-and-effect relationship
between glucose availability and plaque pH fall.57,58 Kleinberg
and coworkers also studied the effects of the nitrogenous
substrate, urea, on plaque pH behaviour and showed the
mirror image profile of the Stephan curve, i.e., a rapid rise in
pH followed by a slow decrease back to baseline.59 Important-
ly, the results with glucose and urea together demonstrated
that both acid and base formation can contribute to plaque pH
and serve as counteracting metabolic forces in the caries
process.59 These studies also led to the recognition that pH
response to substrate challenges, with substrates such as
glucose and urea, is an easy way to measure the dynamics of
acid–base metabolism of plaque biofilm in real time.58
Kleinberg’s more recent research has examined the role of
saliva on the Stephan pH curve. In essence, saliva playsmultiple roles: facilitating fermentable carbohydrate and acid
clearance,60 providing bicarbonate for acid buffering61,62 and
nitrogenous substrates for base formation.59,63 Of particular
importance was the identification of arginine, mainly from
small arginine-containing peptides, as a critical pH rise
factor.63 Arginine metabolism was shown to involve the
previously mentioned arginine deiminase pathway, with
conversion to glutamate and alpha-ketoglutarate and, ulti-
mately, to ammonia, carbon dioxide and acetate.64,65 By
studying the effects of glucose and arginine on numerous
acidogenic oral bacteria in vitro and ex vivo, Kleinberg was able
to establish the central role and characteristic pH behaviours
of arginolytic and non-arginolytic bacteria.64,66 Experiments
with mixed bacteria showed that a higher ratio of arginolytic
to non-arginolytic bacteria resulted in a less cariogenic
Stephan pH curve, and visa versa.67 Importantly, these studies
demonstrated that single bacterial species do not reflect
plaque pH profiles observed in vivo, whereas mixed species
with their integratedmetabolic pathways could reproduce the
different profiles of pH behaviour observed in vivo for
individuals with different levels of caries activity. Kleinberg
concluded that a deficiency in base formation can be as
important in caries development as can excessive acid
formation from fermentable carbohydrate.55
Another beneficial effect of saliva is that it provides a
constant source of calcium and phosphate that helps main-
tains super-saturation with respect to tooth mineral. Ade-
quate calcium and phosphate levels are critical to inhibiting
mineral loss during periods of low pH and promoting mineral
gain when pH returns to neutral. Many studies have focused
on the direct role of these ions in step 2 of the Miller process.
Saliva may have an additional indirect, and possibly more
effective, way of providing calcium and phosphate. When
saliva secretion is stimulated, a rapid rise in pH can occur,
reaching as high as 8.3. Several salivary components come
together in progressively greater amounts as the pH rises
above neutrality. As a result, a complex of glycoprotein and
calcium phosphate forms, named by Kleinberg—Salivary
Precipitin, which is readily incorporated into dental plaque.
Importantly, the calcium phosphate in Salivary Precipitin is 8–
10 times more soluble than the calcium phosphate in tooth
mineral and so it can serve as a sacrificial mineral that will
dissolve preferentially before dissolution of tooth mineral,
whilst providing a source of ions for re-mineralization of
decalcified tooth tissue. In support of this role, Kleinberg has
observed that levels of calcium phosphate carried by Salivary
Precipitin are higher in non-cariogenic than in cariogenic
plaque, and are effective in these buffering and re-minerali-
zation processes.67
These discoveries have provided important understanding
of bacterial metabolism and the mouth’s natural defenses
against dental caries, as well as knowledge of how to
manipulate this metabolism. Together, they provided a basis
for Kleinberg’s design of a therapeutic that behaves like saliva
and is able to change local environmental conditions at the
plaque biofilm–tooth surface interface froma carious to a non-
carious condition, enhancing intra-oral base-forming capabil-
ity with an increase inmineralizing ability.67 The composition
described by Kleinberg comprises arginine, calcium, and
preferably one or more cariostatic anion carriers. Kleinberg’s
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follows: firstly, the arginine favours the formation of base by
the plaque biofilm to counterattack the first stage of the Miller
process and the formation of cariogenic acids. At the same
time, the arginine favours the presence of arginolytic over
non-arginolytic bacteria, helping to maintain a less cariogenic
biofilm flora. Secondly, the insoluble calcium compound
suppresses the solubilization of tooth enamel by mass action
and reduces the release of calcium from tooth mineral when
attacked by plaque acids. Calcium precedes the release of
phosphate from enamel, dentin, cementum, and other
calcium phosphate-containing tissues during acid solubiliza-
tion. This means that it is better to use calcium, rather than
phosphate, as a suppressant because the calcium will attack
the second stage of the Miller caries process at its initiation.
Thirdly, the cariostatic anions are capable of enhancing or
supplementing the anti-caries activities of calcium and
arginine. For example, such anions may provide buffering,
which may enhance the base forming and, thereby, the acid
neutralizing activity of the arginine. Together, the individual
components of the composition are coordinated to simulta-
neously counter both steps of the Miller process.67
The basic research that led to this new technology was
followed by clinical research demonstrating that products
containing it can actually deliver clinically meaningful
benefits in cavity prevention. Only by conducting appropri-
ately designed clinical studies, could the hypotheses underly-
ing the development of the technology be proven to be well
founded. In the first of two caries clinical trials, a fluoride-free
calcium-based toothpaste containing arginine bicarbonate
was evaluated as an alternative to regular fluoride toothpaste.
The results of the study showed that, after two years use of the
products, the fluoride-free arginine bicarbonate toothpaste
reduced the formation of cavities as effectively as 1100 ppm
fluoride toothpaste, demonstrating that the approach is valid
and applicable to toothpaste.68 Review of the scientific
literature indicates that the results for this new fluoride-free
arginine-containing toothpaste are noteworthy, as it is the
first fluoride-free toothpaste to demonstrate comparable
clinical efficacy in preventing cavities to the efficacy of
1100 ppm sodium fluoride toothpaste.4 In the second of the
two clinical trials, the effects of chewing two sugarless mints
containing the technology, twice daily after brushing with
regular fluoride toothpaste, were compared to those of a
placebo mint. The results of the study show that, after one-
year use of themints as an adjunct to normal oral hygiene, the
arginine-containing mint reduced the formation of cavities
significantly more effectively than the placebo mint, once
again demonstrating that the approach is valid.69
Much progress has beenmade since Kleinberg’s early work
in understanding themolecular genetics and the physiological
aspects of ammonia generation and its relationship to caries
and health.70,71 Several studies have shown that loss of alkali-
generating potential in dental plaque through loss of urease
activity has a positive relationship with dental caries experi-
ence.72,73 More importantly, clinical studies have demonstrat-
ed that the in situ production of ammonia, from arginine
naturally present in saliva, via the ADS in dental plaque is
positively associated with reduced caries experience. When
the relative enzymatic activity of ammonia-producing path-ways (both ADS and urease activities) in dental plaque was
compared for caries-free (DMFT=0), caries-experienced
(DMFT4, no active caries for 12 months), and caries-active
subjects (DMFT4 with active caries) subjects, it was found
that the caries-active subjects demonstrated reduced capabil-
ity to generate ammonia. The results of this study demon-
strate that caries status is correlated with both ADS activity
and urease activity.74 Similar observations have also been
reported in an independent study.75 A proof of concept clinical
study has shown that an exogenous source of arginine can
influence ADS activity in both caries-free and caries-active
subjects. In this study, fluoride-free toothpaste with 1.5%
arginine plus calcium carbonate was compared to a 1100 ppm
fluoride toothpaste (silica /NaF) as a positive control which has
been clinically proven to prevent cavity formation. After 4-
weeks of twice-daily brushing, the arginine-containing tooth-
paste group had significantly increased ADS activity. Impor-
tantly, the ADS activity increase was most significant for the
caries-active subjects. This indicates that exogenous arginine
delivered during tooth brushing can reduce caries risk by
increasing ADS activity.766. The development and validation of a new
dentifrice containing 1.5% arginine, an insoluble
calcium compound and 1450 ppm fluoride as
sodium monofluorophosphate
In recent years, there has been a conspicuous trend towards
conservative dentistry and minimal invasive therapy.77–79
Both academic researchers and the practicing dental profes-
sionals recognize that new approaches to intervene earlier in
the caries process are an important step in taking conservative
dentistry and minimal invasive therapy to the next stage. In
fact, the profession are actively looking for new technologies
that are proven to be effective in ‘‘high risk’’ children and
adults.78–81
It is also acknowledged that detection and monitoring of
lesions, in their earliest stages, is critical to changing the
paradigm in caries prevention.1,13,14,20,21,78,79,82–84 Indeed,
traditional caries clinical methods that only detect caries at
the cavitation level have been noted to be an impediment to
the introduction of innovative new technologies. In particular,
it was suggested that enhanced methods of detecting and
monitoring pre-clinical enamel loss would accelerate the
conduct of clinical trials and would, almost certainly, give
more meaningful clinical results. Traditional caries clinical
methods do not allow investigators to evaluate the effects of
an intervention on the disease process, but solely allow
evaluation on the clinical end point, cavities.1 For this reason,
a number of advanced and more discerning techniques, such
as Quantitative Light-induced Fluorescence (QLF) and the
Electrical CariesMonitor (ECM) have been developed, and their
use in clinical trials has been refined and optimized to enable
the detection and monitoring of pre-cavitated lesions over
time.85,86 These advanced techniques are gaining wide
acceptance as state-of-the-art caries detection methods.24
Given the success of fluoride, it would be prudent that any
new caries management strategy recognize and complement
the effects of fluoride, if the goal is to significantly impact the
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are focused on the host tissue as a means of damage control,
once the caries process has been initiated and is in progress,
combining fluoride with an agent that prevents the caries
process at an earlier stage, by targeting the residual plaque
biofilm, would have potential to deliver a step change
improvement in caries prevention.
Based upon its proposed mechanism of action, which is
complimentary to the well-known mechanism of action of
fluoride, argininewith an insoluble calciumcompoundhas the
potential to significantly enhance the caries preventive
benefits of traditional fluoride dentifrices. For this reason, a
new and innovative dentifrice based upon 1.5% arginine,
1450 ppm fluoride, as sodium monofluorophosphate, in an
insoluble calcium base has been developed and clinically
validated.4
Three coronal caries studies, using Quantitative Light-
induced Fluorescence (QLF) tomeasure changes in early caries
lesions in children, have each shown that the new dentifrice
containing 1.5% arginine and 1450 ppm fluoride in a calcium
base is significantly more effective in arresting and reversing
coronal caries lesions than a dentifrice containing 1450 ppm
fluoride alone.87–89 In one study, the new dentifrice was
compared to two control dentifrices; a matched positive
control containing 1450 ppm fluoride alone and a matched
fluoride-free negative control. After six months product use,
improvements from baseline in the representative parameter
DQ (lesion volume) were 50.7%, 32.3% and 11.4% for the new
arginine-containing dentifrice, the positive control dentifrice
and the negative control dentifrice, respectively. The differ-
ences between the negative control and the two fluoride
containing dentifrices (p < 0.001), as well as the differences
between the new dentifrice and the positive control
(p = 0.003), were statistically significant.87 In a second study,
the new dentifrice was compared to two control dentifrices; a
positive control containing 1450 ppm fluoride as sodium
fluoride in a silica base and a matched fluoride-free negative
control. After six months product use, improvements from
baseline in the parameter DQ (lesion volume) were 50.6%,
34.0% and 13.1% for the new arginine-containing dentifrice,
the positive control dentifrice and the negative control
dentifrice, respectively. Once again, the differences between
the negative control and the two fluoride containing denti-
frices (p < 0.001), as well as the differences between the new
dentifrice and the positive control (p = 0.008), were statisti-
cally significant.88 In a third study, the new dentifrice was
compared to a matched positive control dentifrice containing
1450 ppm fluoride alone. After six months product use,
improvements from baseline in the parameter DQ (lesion
volume)were 44.6%and 28.9% for thenewarginine-containing
dentifrice and the positive control dentifrice, respectively. The
difference between the new dentifrice and the positive control
was statistically significant (p < 0.001).89
Two root caries studies in adults have each shown that the
newdentifrice containing 1.5% arginine and 1450 ppmfluoride
in a calcium base is significantly more effective in arresting
and reversing root caries lesions than a dentifrice containing
1450 ppm fluoride alone.90,91 In one study, the new dentifrice
was compared to two control dentifrices; a positive control
containing 1450 ppm fluoride, as sodium fluoride, in a silicabase, and a matched fluoride-free negative control. After six
months product use, clinical hardness measures showed that
only one lesion (0.7%) was worse in the new dentifrice group
compared to 9.0% and 18.2% in the positive and negative
control groups, respectively. In addition, 61.7%, 56.0% and
27.0% lesions showed improvement for the new arginine-
containing dentifrice, the positive control dentifrice and the
negative control dentifrice, respectively. Thedifferences in the
distribution of lesion change scores between the negative
control and the two fluoride containing dentifrices (p < 0.001),
as well as the differences between the new dentifrice and the
positive control (p = 0.006), were statistically significant.90 In
the second study, the new dentifrice was compared to a
matched positive control containing 1450 ppm. After six
months product use, 70.5% of root caries lesions improved
for subjects using the new dentifrice compared to 58.1% for
subjects in the positive control group. The difference in the
number of root caries lesions being hardened in the new
dentifrice and positive control groups was statistically
significant (p < 0.05).91
Finally, a 2-year conventional caries clinical study has
proven that two dentifrices containing 1.5% arginine and
1450 ppm fluoride in a calcium base, one with di-calcium
phosphate and the other with calcium carbonate, are
significantly more effective in preventing the formation of
cavitated caries lesions than a dentifrice containing 1450 ppm
fluoride alone. Three trained and calibrated dentists examined
the children at baseline and after one and two years using the
National Institute of Dental Research Diagnostic Procedures
and Criteria. The number of decayed, missing, and filled teeth
(DMFT) and surfaces (DMFS) for the three study groups were
very similar at baseline, with no statistically significant
differences among groups. After one year, there were no
statistically significant differences in caries increments
among the three groups. After two years, the two groups
using the dentifrices containing 1.5% arginine, an insoluble
calcium compound and 1450 ppm F had statistically signifi-
cantly (p < 0.02) lower DMFT increments (21.0% and 17.7%
reductions, respectively) and DMFS increments (16.5% and
16.5%) compared to the control dentifrice. The differences
between the two groups using the new dentifrices were not
statistically significant. The results of this pivotal clinical
study support the conclusion that dentifrices containing 1.5%
arginine, an insoluble calcium compound, and 1450 ppm
fluoride provide superior protection against caries lesion
cavitation to dentifrices containing 1450 ppm fluoride alone.92
This Special Issue of the Journal of Dentistry reports two of
the coronal and one of the root caries clinical studies.88,89,91 A
Special Issue of the Journal of Clinical Dentistry reports the
additional coronal and root caries studies,87,90 together with a
series of in vivo and in situmechanism of action studies which
demonstrate that this new technology works by targeting
dental plaque to modulate bacterial metabolism and reduce
fluctuations in plaque pH, which reduces de-mineralization
and enhances re-mineralization of early caries lesions.93,94
The following papers in this journal discuss the topics: (1)
dental caries as a dynamic process resulting in a continuumof
lesions from early mineral loss through to cavitation, and the
opportunities that this knowledge presents in terms of
methods available to detect and monitor early reversible
j o u r n a l o f d e n t i s t r y 4 1 s ( 2 0 1 3 ) s 1 – s 1 1S8lesions and the effects of state-of-the art technologies and
products that prevent and treat them, (2) the results of two
clinical studies, one conducted in China and the other
conducted in Thailand, that demonstrate that the new
dentifrice containing 1.5% arginine and 1450 ppm fluoride in
a calcium base is significantly more effective in arresting and
reversing coronal caries lesions than a dentifrice containing
1450 ppm fluoride alone and (3) results of a clinical study
conducted in Brazil that demonstrates that this new dentifrice
is significantly more effective in arresting and reversing the
root caries process in adults than regular fluoride only
dentifrice.7. Summary and conclusions
Global caries prevalence and severity data show that dental
caries is a prevalent condition from childhood through to old
age, despite the decline in caries experience in many
countries. Caries experience for individuals, and populations,
depends upon the balance between increasing consumption
of sugars, which increases caries, and improved oral hygiene
and increasingly effective use of fluoride, which decreases
caries.
Three concepts are fundamental to caries research and the
development of new preventive measures in the future. First,
dental caries is a process,whichmay be arrested and reversed,
in its early stages. Second, dental caries is a continuum of
states ranging from the early pre-clinical to the advanced
clinically detectable lesion. If left untreated, the early
reversible lesion can progress to an irreversible endpoint that
then needs to be restored by a dental professional. Third, the
caries process is a dynamic balance between pathological and
protective factors. Preventive and treatment steps, which
reduce pathological factors and/or increase protective factors
can help in effective management of the caries process.
Two of the key caries risk factors, the susceptible host
tissue and the cariogenic bacteria in the plaque biofilm, are
identified as targets for preventive therapy. The global decline
in caries experience has been largely attributed to the
introduction of fluoride toothpaste. The efficacy of fluoride
toothpaste iswell documented in caries clinical trials. Fluoride
toothpaste works by delivering low levels of fluoride to the
mouth, which are sustained between brushing occasions,
reducing de-mineralization and enhancing re-mineralization.
Thus, fluoride is a protective factor that helps to arrest and
reverse the caries process. However, fluoride does not prevent
the production of acid by cariogenic bacteria, which is the first
step in the caries process. Thus, there is an opportunity for a
step change improvement in caries prevention using a dual
approach of combining an agent, which targets dental plaque,
to control the plaque biofilm and its harmful effects, with
fluoride to target the host tissue.
As the next step in conservative therapy and minimum
intervention, academic researchers and dental professionals
are seeking new technologies to promote re-mineralization of
early caries lesions and reverse the caries process at the
earliest possible stage. They recognize that conventional
clinical methods are inadequate to detect and assess early
caries lesions and the caries process itself. More advancedmethods, such as QLF and ECM, which have been developed,
refined and optimized, offer opportunities to detect, treat and
monitor pre-cavitated lesions. These advanced techniques are
gaining wide acceptance as state-of-the-art caries detection
methods.
A new dentifrice containing 1.5% arginine, an insoluble
calcium compound, and 1450 ppm fluoride has been devel-
oped and validated. Its mode of action is based upon the
arginine deiminase pathway of non-pathogenic arginolytic
bacteria. These bacteria break down arginine to ammonia to
neutralize plaque acids and to preserve undisturbed plaque
biofilm on the tooth surface in a healthy state. As the
mechanisms of action of arginine and fluoride are highly
complementary, the addition of the arginine to a calcium-
based 1450 ppm fluoride toothpaste enhances the anti-caries
efficacy compared to the efficacy of fluoride dentifrices with
the same level of fluoride alone. This has been clinically
proven, using advanced and discerning new detection
methods, in three coronal caries studies in children and two
root caries studies in adults. Additionally, this new dentifrice
has been evaluated in a conventional 2-year caries clinical trial
and has been shown to be statistically significantly more
effective than a dentifrice with fluoride alone in reducing the
progression of caries to cavitation. Importantly, this new
technology offers the potential to meet the unmet needs for
early intervention.Conflict of interest statement
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